Pharmacoepidemiology and Drug Safety

Article	Citations
Accuracy of Japanese claims data in identifying diabetes‐related complications	56
Control yourself: ISPE‐endorsed guidance in the application of self‐controlled study designs in pharmacoepidemiology	40
Core concepts in pharmacoepidemiology: Confounding by indication and the role of active comparators	37
Validation of diagnosis codes to identify hospitalized COVID‐19 patients in health care claims data	34
QTc prolongation in COVID‐19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta‐analysis	30
Core concepts in pharmacoepidemiology: Violations of the positivity assumption in the causal analysis of observational data: Consequences and statistical approaches	28
HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real‐world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force	27
Safety of Andrographis paniculata: A systematic review and meta‐analysis	24
Sodium‐glucose cotransporter‐2 inhibitors and the risk of gout: A Danish population based cohort study and symmetry analysis	23
Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study	23
Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data	23
Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID‐19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 3	22
Core concepts in pharmacoepidemiology: Validation of health outcomes of interest within real‐world healthcare databases	22
Polypharmacy and the risk of drug–drug interactions and potentially inappropriate medications in hospital psychiatry	21
Real‐world evidence to support regulatory decision making: New or expanded medical product indications	21
A COVID‐19‐ready public health surveillance system: The Food and Drug Administration's Sentinel System	20
Validity of claims‐based algorithms for selected cancers in Japan: Results from the VALIDATE‐J study	19
Antidepressant use in Australia and Sweden—A cross‐country comparison	19
High‐dimensional propensity scores for empirical covariate selection in secondary database studies: Planning, implementation, and reporting	18
Utilization of drugs with reports on potential efficacy or harm on COVID‐19 before, during, and after the first pandemic wave	18
Bipolar disorder prevalence and psychotropic medication utilisation in Hong Kong and the United Kingdom	18
Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population‐based cohort studies	17
Validity of claims‐based algorithms to identify neurodevelopmental disorders in children	17
Real‐world data: Assessing electronic health records and medical claims data to support regulatory decision‐making for drug and biological products	17
Chronic opioid use and complication risks in women with endometriosis: A cohort study in US administrative claims	16

Trends in fall‐related mortality and fall risk increasing drugs among older individuals in the United States,1999–2017	16
Core concepts in pharmacoepidemiology: Measures of drug utilization based on individual‐level drug dispensing data	16
Validation of diagnostic coding for interstitial lung diseases in an electronic health record system in Hong Kong	16
Use of hydrochlorothiazide and risk of skin cancer in a large nested case‐control study in Spain	15
Evaluation of more than one billion outpatient prescriptions and eight‐year trend showing a remarkable reduction in antibiotic prescription in Turkey: A success model of governmental interv	15
Incorporating patient generated health data into pharmacoepidemiological research	14
Identification of pregnancies and infants within a US commercial healthcare administrative claims database	14
Validity of ICD‐10‐CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapies	14
Validation of an ICD‐10‐based algorithm to identify stillbirth in the Sentinel System	14
The Chang Gung Research Database: Multi‐institutional real‐world data source for traditional Chinese medicine in Taiwan	14
Using artificial intelligence to identify anti‐hypertensives as possible disease modifying agents in Parkinson's disease	13
Risk of myopericarditis following COVID‐19 mRNA vaccination in a large integrated health system: A comparison of completeness and timeliness of two methods	13
Validity of congenital malformation diagnoses in healthcare claims from a university hospital in Japan	13
Medication‐related problems in older people in Catalonia: A real‐world data study	13
Effect of ICD‐9‐CM to ICD‐10‐CM coding system transition on identification of common conditions: An interrupted time series analysis	13
New‐user and prevalent‐user designs and the definition of study time origin in pharmacoepidemiology: A review of reporting practices	13
Initial opioid prescription patterns and the risk of ongoing use and adverse outcomes	13
Transparency of high‐dimensional propensity score analyses: Guidance for diagnostics and reporting	13
Trends in strong opioid prescribing in Ireland: A repeated cross‐sectional analysis of a national pharmacy claims database between 2010 and 2019	12
Trends in benzodiazepine and alternative hypnotic use in relation with multimorbidity among older adults in Quebec, Canada	12
Validation studies of Japanese administrative health care data: A scoping review	12
Using administrative healthcare database records to study trends in prescribed medication dispensed during pregnancy in Belgium from 2003 to 2017	12
Drug exposure misclassification in pharmacoepidemiology: Sources and relative impact	12
Identifying prescribing cascades in Alzheimer's disease and related dementias: The calcium channel blocker‐diuretic prescribing cascade	12
Multimorbidity measures from health administrative data using ICD system codes: A systematic review	11
Validation of an International Classification of Disease, 10th revision coding adaptation for the Charlson Comorbidity Index in United States healthcare claims data	11
What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring?	11
A systematic review of how missing data are handled and reported in multi‐database pharmacoepidemiologic studies	11
Generalizability and accuracy of IBM MarketScan health risk assessment instrument data for augmentation of commercial claims data	11
Global COVID‐19 pandemic and reporting behavior ‐ An analysis of the Food and Drug Administration adverse events reporting system	11
Chronic pain patients' willingness to share personal identifiers on the web for the linkage of medico‐administrative claims and patient‐reported data: The chronic pain treatment cohort	11
Performance assessment of different machine learning approaches in predicting diabetic ketoacidosis in adults with type 1 diabetes using electronic health records data	11
Drug interactions in hospital prescriptions in Denmark: Prevalence and associations with adverse outcomes	11
Validation of diagnosis codes in healthcare databases in Taiwan, a literature review	11
An investigation on the association between sodium glucose co‐transporter 2 inhibitors use and acute pancreatitis: A VigiBase study	10
Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting	10
Association between different diabetes medication classes and risk of Parkinson's disease in people with diabetes	10
Use of negative controls in a prescription sequence symmetry analysis to reduce time‐varying bias	10
Categorization of COVID‐19 severity to determine mortality risk	10
A systematic review and meta‐analysis of observational studies of the association between the use of incretin‐based therapies and the risk of pancreatic cancer	10
Building an active medical product safety surveillance system in Taiwan: Adaptation of the U.S. Sentinel System common data model structure to the National Health Insurance Research Database in Taiwan	10
Effectiveness of risk minimisation measures for valproate: A drug utilisation study in Europe	10
Identification of rheumatoid arthritis in German claims data using different algorithms: Validation by cross‐sectional patient‐reported survey data	10
Greedy caliper propensity score matching can yield variable estimates of the treatment‐outcome association—A simulation study	10
Developing algorithms for identifying major structural birth defects using automated electronic health data	10
Core concepts in pharmacoepidemiology: Key biases arising in pharmacoepidemiologic studies	9
Postoperative inpatient utilization of opioid and opioid‐sparing analgesics in the United States hospitals, 2007–2017	9
Differential frequency in imaging‐based outcome measurement: Bias in real‐world oncology comparative‐effectiveness studies	9
Using machine learning to identify diabetes patients with canagliflozin prescriptions at high‐risk of lower extremity amputation using real‐world data	9
Chronic prescription opioid use in pregnancy in the United States	9

Pharmacovigilance network as an additional tool for the surveillance of antimicrobial resistance	9
Validity of a model using routinely collected data for identifying infections following gastric, colon, and liver cancer surgeries	9
Validity of identification algorithms combining diagnostic codes with other measures for acute ischemic stroke in MID‐NET®	9
SGLT‐2 inhibitors and the risk of hospitalization for community‐acquired pneumonia: A population‐based cohort study	9
Factors associated with the use of the prescription monitoring program by prescribers and pharmacists in Texas	9
Evaluation of the key prescription sequence symmetry analysis assumption using the calcium channel blocker: Loop diuretic prescribing cascade	9
Use of a mobile app to capture supplemental health information during pregnancy: Implications for clinical research	8
Association between antidepressant use in pregnancy and gestational diabetes mellitus: Results from the Norwegian Mother, Father and Child Cohort Study	8
More extreme duplication in the U.S. FDA FAERS database and a suggested check point for disproportionality analysis	8
More extreme duplication in FDA Adverse Event Reporting System detected by literature reference normalization and fuzzy string matching	8
COVID‐19 pharmacotherapy utilization patterns during pregnancy: International Registry of Coronavirus Exposure in Pregnancy	8
Comparison of the incidence of bleeding between baloxavir marboxil and other anti‐influenza drugs among outpatients with influenza virus infection: A retrospective cohort study using an employment‐bas	8
Overview of the European post‐authorisation study register post‐authorization studies performed in Europe from September 2010 to December 2018	8
Use of hydrochlorothiazide in Denmark following publication of skin cancer risk findings	8
Sensitivity and specificity in signal detection with the reporting odds ratio and the information component	8
Prescribing of menopausal hormone therapy in Germany: Current status and changes between 2004 and 2016	8
Use of negative control outcomes to assess the comparability of patients initiating lipid‐lowering therapies	8
Nonsteroidal anti‐inflammatory drugs associated acute kidney injury in hospitalized children: A systematic review and meta‐analysis	8
Mobile apps for quick adverse drug reaction report: A scoping review	8
Analysis of the US FDA adverse event reporting system to identify adverse cardiac events associated with hydroxychloroquine in older adults	8
Hydrochlorothiazide and risk of melanoma subtypes	8
IncidencePrevalence: An R package to calculate population‐level incidence rates and prevalence using theOMOPcommon data model	8
Inflammatory bowel disease patients provide reliable self‐reported medical information: A multicentre prospective pharmacovigilance monitoring system	8
Impact of adherence to drugs for secondary prevention on mortality and cardiovascular morbidity: A population‐based cohort study. IMPACT study	8
Impact of direct‐acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers	8
The utility of real‐world evidence for benefit‐risk assessment, communication, and evaluation of pharmaceuticals: Case studies	7
Inventory of real‐world data sources in Japan: Annual survey conducted by the Japanese Society for Pharmacoepidemiology Task Force	7
Trends in the use of disease‐modifying therapies among reproductive‐aged women with multiple sclerosis in the United States from 2010 to 2019	7
Drug product dispensing and estimates of use in a general population survey as a signal detection problem	7
Validation to correct for outcome misclassification bias	7
Pharmacological and epidemiological considerations while constructing treatment episodes using observational data: A simulation study	7
Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data: Infliximab with thiopurines compared to infliximab monotherapy	7
Very high PD‐L1 expression as a prognostic indicator of overall survival among patients with advanced non‐small cell lung cancer receiving anti‐PD‐(L)1 monotherapies i	7
Proton pump inhibitors may enhance the risk of citalopram‐ and escitalopram‐associated sudden cardiac death among patients receiving hemodialysis	7
Health outcomes coding trends in the US Food and Drug Administration's Sentinel System during transition to International Classification of Diseases‐10 coding system: A brief review	7
Prevalence and distribution of high‐risk prescription opioid use in the United States, 2011–2016	7
Core concepts in pharmacoepidemiology: Fundamentals of the cohort and case–control study designs	7
Identifying frequent drug combinations associated with delirium in older adults: Application of association rules method to a case‐time‐control design	7
Thromboembolic events after Ad.26.COV2.S COVID‐19 vaccine: Reports to the Vaccine Adverse Event Reporting System	7
Methods for drug safety signal detection using routinely collected observational electronic health care data: A systematic review	7
Estimation of adverse drug reaction reporting in Iran: Correction for underreporting	7
Hepatic adverse drug reactions in Malaysia: An 18‐year review of the national centralized reporting system	7
Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes inU.S.administrative claims data	7
Validation of an electronic algorithm for Hodgkin and non‐Hodgkin lymphoma in ICD‐10‐CM	7
Tell me what you want, what you really really want: Estimands in observational pharmacoepidemiologic comparative effectiveness and safety studies	6
Acute kidney injury identification for pharmacoepidemiologic studies: Use of laboratory electronic acute kidney injury alerts versus electronic health records in Hospital Episode Statistics	6
International trends in prescription opioid sales among developed and developing economies, and the impact of the COVID‐19 pandemic: A cross‐sectional analysis of 66 countries	6
Method used to identify adenomyosis and potentially undiagnosed adenomyosis in a large, U.S. electronic health record database	6
A data‐informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data	6
Validation of claims‐based algorithms to identify non‐live birth outcomes	6
Data sources for drug utilization research in Latin American countries—A cross‐national study: DASDUR‐LATAM study	6
Glucosamine and lower mortality and cancer incidence: Selection bias in the observational studies	6
Development and validation of an electronic health records‐based opioid use disorder algorithm by expert clinical adjudication among patients with prescribed opioids	6
Where to begin? Thirty must‐read papers for newcomers to pharmacoepidemiology	6
Using Joinpoint regression for drug utilization research: Tutorial and case study of prescription opioid use in the United States	6
Effect of concomitant antiplatelet therapy on ischemic and hemorrhagic events in patients taking oral anticoagulants for nonvalvular atrial fibrillation in daily clinical practice	6
Predicting obesity and smoking using medication data: A machine‐learning approach	6
Validation of serostatus of rheumatoid arthritis using ICD‐10 codes in administrative claims data	6
Emergency hospitalizations for adverse drug events in China: Clinical pharmacists' approach to assessment and categorization	6
Using structural topic modelling to reveal patterns in reports on opioid drugs in a pharmacovigilance database	6
Evaluating opioid analgesic prescribing limits: A narrative review	6
Assessing polypharmacy in the older population: Comparison of a self‐reported and prescription based method	6
	6
Suitability of databases in the Asia‐Pacific for collaborative monitoring of vaccine safety	6
Off‐label drug use in neonates and infants in Spain: A five‐year observational study	6
Signals from the Dutch national spontaneous reporting system: Characteristics and regulatory actions	6
The role of prenatal exposure to antidepressants, anxiolytic, and hypnotics and its underlying illness on the risk of miscarriage using BIFAP database	6
Machine learning for improving high‐dimensional proxy confounder adjustment in healthcare database studies: An overview of the current literature	6
Real‐world reproducibility study characterizing patients newly diagnosed with multiple myeloma using Clinical Practice Research Datalink, a UK‐based electronic health records database	6
	6
Comparative neurological safety of fluoroquinolones versus therapeutic alternatives	6
Relation between anticholinergic burden and cognitive impairment: Results from the Monzino 80‐plus population‐based study	6
Time‐related biases in perinatal pharmacoepidemiology: A systematic review of observational studies	6
Ondansetron use in early pregnancy and the risk of late pregnancy outcomes	6
Use of preventive drugs during the last year of life in older adults with cancer or chronic progressive diseases	5
Outcomes in patients with lung cancer treated with crizotinib and erlotinib in routine clinical practice: A post‐authorization safety cohort study conducted in Europe and in the United States	5
Evaluation of the efficacy and safety of romosozumab (evenity) for the treatment of osteoporotic vertebral compression fracture in postmenopausal women: A systematic review and meta‐analysis of random	5
Alternative analytic and matching approaches for the prevalent new‐user design: A simulation study	5
Validity of hospital ICD‐10‐GM codes to identify anaphylaxis	5
Bias of time‐varying exposure effects due to time‐varying covariate measurement strategies	5

SARS‐CoV‐2 vaccine‐related adverse events in Zimbabwe: The need to strengthen pharmacovigilance in resource‐limited settings	5
“Take up to eight tablets per day”: Incorporating free‐text medication instructions into a transparent and reproducible process for preparing drug exposure data for pharmacoepidemiology	5
Validation of international classification of diseases, tenth revision, clinical modification diagnosis codes for heart failure subtypes	5
Prediction of post‐vaccination Guillain‐Barré syndrome using data from a passive surveillance system	5
Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study	5
Risk of delirium associated with antimuscarinics in older adults: A case‐time‐control study	5
Antibiotic utilization within 18 community hospitals in the United States: A 5‐year analysis	5
Novel methods for pregnancy drug safety surveillance in the FDA Sentinel System	5
Evaluating awareness, knowledge and practice of healthcare professionals following implementation of a revised pregnancy prevention programme for isotretinoin in Ireland: A multi‐stakeholder cross‐sec	5
Women on diuretics have a higher risk of hospital admission because of hyponatremia than men	5
Artificial intelligence in pharmacovigilance: Do we need explainability?	5
Association of baloxavir marboxil prescription with subsequent medical resource utilization among school‐aged children with influenza	5
Validation of algorithms to select patients with multiple myeloma and patients initiating myeloma treatment in the national Veterans Affairs Healthcare System	5
Effectiveness of risk minimisation measures for valproate: A cross‐sectional survey among physicians in Europe	5
Feasibility of using Clinical Practice Research Datalink data to identify patients with chronic obstructive pulmonary disease to enrol into real‐world trials	5
A comparison of confounder selection and adjustment methods for estimating causal effects using large healthcare databases	5
Risk of major congenital malformations associated with first‐trimester exposure to propulsives: A health administrative database study in Japan	5
Utilization of nonguideline concordant antibiotic treatment following acute otitis media in children in the United States	5
Exposure to nitrosatable drugs during pregnancy and childhood cancer: A matched case–control study in Denmark, 1996–2016	5
Increasing rates of buprenorphine diversion in the United States, 2002 to 2019	5
Prescription of antibiotics in the medical care of newly arrived refugees and migrants	4
Statin persistence and adherence among older initiators: A nationwide cohort study using the national health insurance claims database in Japan	4
Effectiveness and use of reverse transcriptase polymerase chain reaction point of care testing in a large‐scale COVID‐19 surveillance system	4
Validity of claims data for identifying cancer incidence in the Japan public health center‐based prospective study for the next generation	4
Potentially inappropriate medication use by level of polypharmacy among US Veterans 49–64 and 65–70 years old	4
Prescribed drugs in 27 000 individuals after diagnosis of colorectal cancer: A population‐based cohort study	4
The impact of regulatory restrictions on pregabalin use in Saudi Arabia: An interrupted time series analysis	4
Incidence and outcomes of adverse drug reactions to first‐line anti‐tuberculosis drugs and their effects on the quality of life: A multicenter prospective cohort study	4
A review of pregnancy and lactation postmarketing studies required by the FDA	4
Investigating drug safety in pregnancy based on the German Pharmacoepidemiological Research Database (GePaRD): A proof‐of‐concept analysis on the association between valproate and spina bifida	4
Direct healthcare costs of chronic kidney disease management in Italy: What cost‐savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis‐stimulating agents?	4
Perinatal pharmacoepidemiology: How often are key methodological elements reported in publications?	4
Real world data to identify target population for new CAR‐T therapies	4
Does additional monitoring status increase the reporting of adverse drug reactions? An interrupted time series analysis of EudraVigilance data	4
Use of α1‐adrenoceptor antagonists tamsulosin and alfuzosin and the risk of Alzheimer's disease	4
A systematic, concept‐based method of developing the exposure measure for drug safety and effectiveness studies	4
Comparing LASSO and random forest models for predicting neurological dysfunction among fluoroquinolone users	4
Off‐label low dose amitriptyline for insomnia disorder: Patient‐reported outcomes	4
Assessing heterogeneity of electronic health‐care databases: A case study of background incidence rates of venous thromboembolism	4
Self‐medication practice with antimalarials & the determinants of malaria treatment‐seeking behavior among postpartum mothers in a rural community in Nigeria	4
Potentially inappropriate medications in nursing homes and the community older adults using the French health insurance databases	4
mRNA COVID‐19 vaccination early in pregnancy and the risk of spontaneous abortion in an international pregnancy registry	4
Validation of ICD‐10 hospital discharge diagnosis codes to identify incident and recurrent ischemic stroke from a US integrated healthcare system	4
General practitioner prescribing trends among pediatric patients in the United Kingdom: 1998–2018	4
Association between pre‐admission anticoagulation and in‐hospital death, venous thromboembolism, and major bleeding among hospitalized COVID‐19 patients in Japan	4
Telemedicine use among patients with metastatic breast cancer during the COVID‐19 pandemic: Differences by race, age, and region	4
Development of a multivariate prediction model to identify individual case safety reports which require clinical review	4
Cardiovascular events and all‐cause mortality in patients with chronic obstructive pulmonary disease using olodaterol and other long‐acting beta2‐agonists	4
Use of intravenous iron and risk of anaphylaxis: A multinational observational post‐authorisation safety study in Europe	4
Validating a novel algorithm to identify patients with autoimmune hepatitis in an administrative database	4
Linkage of public health and all payer claims data for population‐level opioid research	4
Intra‐articular and soft‐tissue corticosteroid injections and risk of infections: Population‐based self‐controlled‐risk‐interval design	4
Ways COVID‐19 may impact unrelated pharmacoepidemiologic research using routinely collected data	4
Population‐based prevalence of polypharmacy and patterns of medication use in southwestern Iran: A cross‐sectional study	4
Association between methylphenidate and risk of myocardial infarction: A multinational self‐controlled case series study	3
Proton pump inhibitors long term use‐trends and patterns over 15 years of a large health maintenance organization	3
The most common medications dispensed to lactating persons: An electronic health record‐based approach	3
Systematic evaluation of the efficacy‐effectiveness gap of systemic treatments in extensive disease small cell lung cancer	3
Antibacterial‐associated acute kidney injury among older adults: A post‐marketing surveillance study using the FDA adverse events reporting system	3
Management of epilepsy in Lebanon: Medication reviews and drug‐related problems	3
The risk of miscarriage after COVID‐19 vaccination before and during pregnancy	3
Detecting deviations from the efficacy and safety results of single‐arm trials using real‐world data: The case of a CAR‐T cell therapy in B‐cell lymphoma	3
Monitoring real‐life utilization of pembrolizumab in advanced melanoma using the Portuguese National Cancer Registry	3
Quality of rheumatoid arthritis recording in United Kingdom Clinical Practice Research Datalink Aurum	3
The marked oscillatory pattern in prescription opioid utilization in Canada since 2000: Selected observations and questions for outcomes and policy	3
Role of private prescriptions in the long‐term use of benzodiazepines and Z‐drugs: A patient‐related follow‐up study	3
Pragmatic considerations for negative control outcome studies to guide non‐randomized comparative analyses: A narrative review	3
	3
A comparison of decision and timing of safety related labeling changes for new drugs approved both in Japan and the United States	3
Risk of neuropsychiatric adverse events associated with varenicline treatment for smoking cessation among Dutch population: A sequence symmetry analysis	3
Trends in use of proton pump inhibitors among adults in the United States from 1999 to 2018	3
Trends in antipsychotic use for youth with attention‐deficit/hyperactivity disorder and disruptive behavior disorders	3
Outpatient insulin‐related adverse events due to mix‐up errors: Findings from two national surveillance systems, United States, 2012–2017	3
	3
High‐throughput screening for prescribing cascades among real world statin initiators	3
ABSTRACTS of ICPE 2022, the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Copenhagen, Denmark, 26–28 August, 2022	3
Optimizing therapeutic decision‐making for off‐label medicines use: A scoping review and consensus recommendations for improving practice and research+	3
	3
Exploring parity in female authorship of pharmacoepidemiology articles: A case study of the Canadian Network for Observational Drug Effect Studies and its citing articles	3
Development and evaluation of a proxy for baseline ECOG PS in advanced non‐small cell lung cancer, bladder cancer, and melanoma: An electronic health record study	3
Implementation of risk minimization measures to reduce the risk of tuberculosis among tumor necrosis factor medication users	3
Statin use and the risk of progression to vision threatening diabetic retinopathy	3
Measured and accounted‐for confounding in pharmacoepidemiologic studies: Some thoughts for practitioners	3
Validation of claims‐based algorithms to identify patients with psoriasis	3
Observed‐over‐Expected analysis as additional method for pharmacovigilance signal detection in large‐scaled spontaneous adverse event reporting	3
Impact of lifestyle and socioeconomic position on use of non‐steroidal anti‐inflammatory drugs: A population‐based cohort study	3
Biases associated with epidermal necrolysis reporting in pharmacovigilance: An exploratory analysis using World Health Organization VigiBase	3
Medicine use in children aged under 12 years—Population survey in Finland	3
The risk of melanoma with rasagiline compared with other antiparkinsonian medications: A retrospective cohort study in the United States medicare database	3
Antibiotic utilisation in primary and revision total hip replacement patients: A registry linkage cohort study of 106 253 patients using the Australian Orthopaedic Association National Joint Replaceme	3
Impact of EMA regulatory label changes on hydroxyzine initiation, discontinuation and switching to other medicines in Denmark, Scotland, England and the Netherlands: An interrupted time ser	3
Validation of diagnostic coding for bronchiectasis in an electronic health record system in Hong Kong	3
Selective serotonin reuptake inhibitors, post‐treatment sexual dysfunction and persistent genital arousal disorder: A systematic review	3
Risk of antibiotic treatment failure in premenopausal women with uncomplicated urinary tract infection	3
	3